101 
Market Cap
Stock Chart
ResMed - 30 Day Poll
Recent BLOGS About ResMed Add New
Latest Company News
|
ResMed is Among the Companies in the Health Care Equipment Industry With the Lowest Relative Performance (RMD, AMMD, SYK, NUVA, MELA)
Comtex Smartrend - Jul 27, 2010 By Chip Brian Below are the top five companies in the Health Care Equipment industry as measured by lowest relative performance. This analysis was based on yesterday's trading activity as we ...
|
|
ResMed head told off
Sydney Morning Herald - Jul 27, 2010 RESMED chief Kieran Gallahue has been pinged by the Australian Securities Exchange for not telling the market in time about a change in his shareholdings. The ASX said there was a change in Mr ...
Resmed's boss pinged over laggardly disclosure - WA today |
|
Top-Notch Mid-Cap Stock Picks
Investopedia - Jul 26, 2010 Through nearly seven months of 2010 the S&P 500 Index, composed of mainly large-cap stocks, is sitting where it started the year. During the same time frame the S&P Mid-Cap 400 Index has been able ...
|
|
William Blair Reiterates Outperform Rating on ResMed (RMD)
Benzinga - Jul 26, 2010 William Blair is out with a research report this morning, where it reiterates its Outperform rating on ResMed Inc. (NYSE: RMD). The WB analysts said, “ResMed reports fiscal fourth-quarter results ...
|
|
SmarTrend Watching for Pullback in Shares of ResMed After 2.16% Gain (RMD)
Comtex Smartrend - Jul 26, 2010 By Chip Brian ResMed (NYSE:RMD) traded in a range yesterday that spanned from a low of $64.01 to a high of $65.76. Yesterday, the shares gained 2.16%, which took the trading range above the 3-day ...
|
|
Hologic Inc. has Investors Worried; HOLX, MDT, RMD
Learning Markets - Jul 22, 2010 Hologic Inc. (HOLX) [Chart - Analysis - News] established a new 52-week low yesterday at $13.26. Clearly investors are not enthusiastic about the firm's prospects. The decline was accompanied by ...
|
|
ResMed Introduces New Mask for Pediatric OSA Patients
news Stories - Jul 20, 2010 ResMed, San Diego, announces the release of the Mirage Micro™ for Kids nasal mask. This is ResMed's second patient interface for the treatment of obstructive sleep apnea in children and now comes ...
|
|
Money Flow Positive for ResMed Inc.; RMD
Learning Markets - Jul 20, 2010 ResMed Inc. (RMD) [Chart - Analysis - News] lost some ground during trading yesterday, but it appears there is some bullish pressure building up in the background. Looking at yesterday's money ...
|
Website
Videos related to ResMed
Company Profile
ResMed (NYSE: RMD and ASX: RMD) is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other respiratory disorders. ResMed operates in over 68 countries via 18 direct offices and a network of distributors with extensive knowledge and experience of local markets.
ResMed's device for treating obstructive sleep apnea (OSA), a major subset of SDBaddresses nasal continuous positive airway pressure (CPAP) and provided the first successful noninvasive treatment of OSA. SDB affects around 20% of the adult population, making it as widespread as diabetes or asthma. However, awareness is low and we believe that about 90% of people who have OSA remain undiagnosed and untreated.
The term “sleep-disordered breathing” includes a spectrum of respiratory disorders ranging in severity from snoring to OSA. OSA occurs when the airway temporarily collapses during sleep, preventing or restricting breathing for up to ten seconds or more. Such events can occur several hundred times a night severely disrupting sleep.
Financial snapshot:
Revenue for the June 2009 quarter was US$252.0 million, a 7% increase over the quarter ended June 30, 2008.
Income from operations was US$57.9 million and net income was US$45.4 million, an increase of 57% and 53%, respectively, compared to the quarter ended June 30, 2008.
Cash on hand was approx. US$415M June 30, 2009.
The company continues to invest approximately 6% of revenues in research and product development.